Study Summary
This trial is testing whether proton therapy can shrink tumors in patients with head and neck cancer.
- Head and Neck Cancer
- Head and Neck Cancer of Unknown Primary
- Hypopharyngeal Cancer
- Laryngeal Cancer
- Metastatic Lymph Node Cancer
- Nasal Cavity Cancer
- Oral Cancer
- Paranasal Sinus Cancer
- Salivary Gland Cancer
- Skin Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 9 Secondary · Reporting Duration: Up to 10 years
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Arm A (IMPT, cisplatin)
1 of 2
Arm B (IMPT, cisplatin)
1 of 2
Experimental Treatment
117 Total Participants · 2 Treatment Groups
Primary Treatment: Cisplatin · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 13 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are we currently enrolling people for this research project?
"Yes, this information can be found on clinicaltrials.gov. The trial was first advertised on February 21st 2021 and the most recent update was April 6th 2022." - Anonymous Online Contributor
Are there other examples in the medical literature of Cisplatin being used in treatment?
"City of Hope Comprehensive Cancer Center first studied cisplatin in 1997 and, as of now, 1198 trials have been completed while 773 are ongoing. A considerable number of these active studies are based in Rochester, Minnesota." - Anonymous Online Contributor
What is the primary purpose that Cisplatin is prescribed?
"Cisplatin is used to treat neoplasm metastasis and other conditions like advanced ovarian cancer. It may be employed when standard therapies have failed or in advance directives." - Anonymous Online Contributor
What is the projected sample size for this experiment?
"Yes, this study is open for recruitment and the clinicaltrials.gov website has the most recent information. The trial was first posted on February 21st, 2021 and was edited April 6th, 2022. There are plans to enroll 117 patients at 2 sites." - Anonymous Online Contributor
Does the FDA sanction use of Cisplatin?
"Cisplatin received a score of 2 from our team because while there is some data suggesting it is safe, none of the available information points to this medication being effective." - Anonymous Online Contributor